Facebook Twitter Instagram
    Facebook Twitter YouTube
    Latest Articles
    • Recruitment Section at the 50 Plus Show
    • Personal finance and property expert Sinead Ryan to speak at The 50 Plus Show
    • Life is for living….
    • Your chance to win the Fantastic Finger Puppet Story Set with Nursery Rhymes from mimitoys.ie
    • Mimitoys.ie, one the largest selection of children’s puppets in Ireland are exhibiting at the 50 Plus Show
    • Improve your Digital Skills at The 50 Plus Show
    • Seniorline are celebrating 25 years at the 50 Plus Show
    • Driving Life with Conor Faughnan. Episode 36: Conor meets Charlie McGettigan
    Senior Times
    Podcasts
    • Home
    • News
    • Features
      1. Driving Life
      2. Fashion & Beauty
      3. Finance
      4. Food & Wine
      5. Further Education
      6. Galleries
      7. Gardening
      8. IRISH GEN POD SERIES
      9. Health
      10. Hobbies & Pastimes
      11. Legal
      12. Literature
      13. Nostalgia
      14. Profiles
      15. 50 Plus Show
      16. Sport
      17. Travel
      18. What’s On
      Featured
      February 15, 20230

      SeniorTimes Rewind – Mike Murphy talks to Author, Deirdre Purcell

      Recent
      March 21, 2023

      Your chance to win the Fantastic Finger Puppet Story Set with Nursery Rhymes from mimitoys.ie

      March 19, 2023

      Driving Life with Conor Faughnan. Episode 36: Conor meets Charlie McGettigan

      March 19, 2023

      Alix Gardner Cooking Demo’s at the 50 Plus Show

    • Podcast
    • Competitions
    • 50 Plus Show
      • Whats On
      • Register
    • Magazine
      • Previous Issues
      • Subscribe
      • Advertise
    • Meeting Place
    • Contact
    Senior Times
    You are at:Home»News»Neuromod announces major European expansion for Irish-made Lenire tinnitus treatment medical device
    PIC JULIEN BEHAL PHOTOGRAPHY Pictured (l-r) is Dr Ross O’Neill, CEO of Irish medical device company Neuromod Devices Ltd and Mr. Brendan Conlon, Chief Medical Officer of Neuromod Devices

    Neuromod announces major European expansion for Irish-made Lenire tinnitus treatment medical device

    0
    By Senior Times on July 13, 2021 News
    • Irish MedTech company make ground-breaking treatment device available to more than 7 million tinnitus sufferers in the UK
    • Neuromod announces partnership with The Tinnitus Clinic and launches telemedicine service in UK
    • Lenire tinnitus treatment device also launched in Switzerland

    Irish medical device company, Neuromod Devices Ltd, has announced a major expansion of its tinnitus treatment device, Lenire ® into two new European countries. Lenire is now available to people with tinnitus through specialist partner clinics in the United Kingdom and Switzerland.

    Neuromod specialises in non-invasive neuromodulation technologies and has developed Lenire, the first non-invasive bimodal neuromodulation tinnitus device, clinically proven in large-scale clinical trials to soothe and relieve tinnitus.

    Tinnitus affects between 10 and 15% of the global population. The company estimates that approximately eight million people across the two countries suffer from tinnitus, a condition commonly known as ‘ringing in the ears’.

    Speaking on this news, Dr Ross O’Neill, CEO of Neuromod Devices said: “I am absolutely delighted to announce our entry into two really important markets: the UK and Switzerland. As the company has scaled up over the past 12 months, as well as our operations in Ireland, Germany, Austria and Belgium, we’ve been focusing on the logistical challenges of making Lenire available to patients in as many European countries as possible. We had been treating a small number of UK-resident patients via our telemedicine service, so it’s good to be able to expand the provision of our services and the Lenire device in these countries”.

    The Lenire tinnitus treatment device is available to people with tinnitus through The Tinnitus Clinic’s network of seven locations across the UK or online via the company’s Neuromod Medical tinnitus telemedicine service.

    The Tinnitus Clinic’s audiologists will provide Lenire to patients, as well as devising and monitoring their tinnitus treatment plans using the device. The Tinnitus Clinic is the leading provider of the latest evidence-based tinnitus treatments in the UK, with clinics in London, Bristol, Leeds, Leicester, Manchester, Newcastle, and Stirling (Scotland).

    Patients in the United Kingdom can also opt to have tinnitus assessments online via the company’s telemedicine service, launched earlier this year in Ireland, which has proved to be popular. The service is delivered through Neuromod Medical, a centre of excellence for tinnitus care, based at the Hermitage Medical Clinic in Dublin and aims to provide patients with quick access to tinnitus care, without waiting lists.

    With this service patients can get assessed, fitted for the Lenire device and complete follow up appointments with their healthcare professional via video call from the comfort of their own homes, using a mobile device or home computer.

    Lenire has also launched in Switzerland, where the device is available to tinnitus patients from 10 clinical partners throughout the country, in places such as Geneva, Bern and Basel. A full list of European partners can be viewed at the Lenire website.

    Dr O’Neill continued: “Finding an effective and long-lasting treatment for tinnitus has been a source of stress for tinnitus patients around the world for a long time. Recently, with tinnitus being a common symptom of long COVID, the demand for an effective tinnitus therapy has increased. At Neuromod, our goal with Lenire is to improve the quality of life of those suffering from tinnitus and this is what motivates us to bring this treatment to as many people as we can. The results of large-scale clinical trials, involving more than 500 participants, are very positive, as are the real-world outcomes for our patients in Ireland and Germany so this is a very exciting time for the company”.

    Neuromod has been advancing the commercialisation of Lenire across Europe having opened its German office in Forchheim, Bavaria last year. Since then, the company has made Lenire available to patients in Germany by taking on 57 partners who make the device and its treatment plan available in 96 clinics throughout Germany. Neuromod also has three partner clinics in Austria.

    The company, which raised €10.5 million in an oversubscribed Series B financing round late last year, has been scaling manufacturing of the Lenire device to meet demand in Europe. This funding has also seen the employee numbers at the company grow by more than 50% in six months. which is being used to expand European commercialisation and scale-up manufacturing of the Lenire device to meet demand.

    Lenire is prescribed and fitted under the supervision of a qualified healthcare professional who specialises in the field of tinnitus treatment such as audiologists and Consultant Otolaryngologists or ENT (Ear, Nose and Throat) surgeons.

    The device has been used in large-scale clinical trials, the most recent of which, involving 326 participants, delivered dramatic improvements in patients’ tinnitus symptoms[i]. 86.2% of treatment-compliant participant reported an improvement in their tinnitus symptoms after a 12-week treatment period.  When followed up 12 months post treatment, 80.1% of these participants had sustained the improvements. This study represents one of the largest and longest followed-up clinical trial ever conducted in the tinnitus field.[ii]

    Spread the love
    hearing tinnitus
    Senior Times
    • Website
    • Facebook
    • Instagram
    • LinkedIn

    Senior Times publishes Senior Times magazine and are producers of the SeniorTimes Podcasts. They are also organisers of The 50 Plus Show run throughout the country

    Related Posts

    Life is for living….

    Improve your Digital Skills at The 50 Plus Show

    The Dublin Assay Office is recruiting a Part-Time Accounts/Administration Assistant

    Comments are closed.

    Driving Life Podcasts

    Gen Pod Series

    Search the Site
    Spotify

    Subscribe

    Our Podcasts

    Senior Times Podcast Platform · Next Up
    Subscribe to our Newsletter
    * indicates required
    Dublin
    March 30, 2023, 7:42 pm
    Mostly cloudy
    Mostly cloudy
    12°C
    real feel: 8°C
    wind speed: 6 m/s SSE
    sunrise: 7:04 am
    sunset: 7:56 pm
    Forecast March 30, 2023
    day
    Mostly cloudy with showers
    Mostly cloudy with showers
    15°C
    wind speed: 4 m/s SW
    night
    Rain
    Rain
    8°C
    wind speed: 5 m/s ESE
     
    Follow Us On Facebook
    Follow us on YouTube
    Follow us on Twitter
    Tweets by @seniortimesmag
    Copyright © 2023 Sports & Leisure. Designed by clikcreative.com.

    Type above and press Enter to search. Press Esc to cancel.